HEPN1, a novel gene that is frequently down-regulated in hepatocellular carcinoma, suppresses cell growth and induces apoptosis in HepG2 cells

Journal of Hepatology

Volumn 39, Issue 4, 2003, Pages 580-586

  Moh, Mei Chung ^a   Lee, Lay Hoon ^a   Yang, Xiaodong ^b   Shen, Shali ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b No 6 Hospital of Chongqing   (China)

Author keywords

Apoptosis; Growth inhibition; Hepatocellular carcinoma; HepG2; Novel gene

Indexed keywords

GENE PRODUCT; HEPN1 PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; APOPTOSIS; ARTICLE; BIOASSAY; BIOINFORMATICS; CANCER INHIBITION; CELL VIABILITY; CHROMOSOME 11Q; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; GENE MAPPING; GENE SEQUENCE; GENE SILENCING; GENETIC ANALYSIS; GENETIC TRANSFECTION; HEPN1 GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER; LIVER CELL CARCINOMA; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE DISTRIBUTION; TUMOR SUPPRESSOR GENE;

EID: 0141563413     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(03)00359-3     Document Type: Article

References (18)

1. Akriviadis EA, Llovet JM, Efremidis SC, Shouval D, Canelo R, Ringe B, et al. Hepatocellular carcinoma. Br J Surg 1998;85:1319-1331.
2. Blumherg BS, Larouze B, London WT, Werner B, Hesser JE, Millman I, et al. The relation of infection with hepatitis B agent to primary hepatic carcinoma. Am J Pathol 1975;81:669-682.
3. Mor E, Kaspa RT, Sheiner P, Schwartz M. Treatment of hepatocellular carcinoma associated with cirrhosis in the era of liver transplantation. Ann Intern Med 1998;129:643-653.
4. Alpert ME, Hutt MS, Wogan GN, Davidson CS. Association between aflatoxin content of food and hepatoma frequency in Uganda. Cancer 1971;28:253-260.
5. Montesano R, Hainaut P, Wild CP. Hepatocellular carcinoma: from gene to public health. J Natl Cancer Inst 1997;89:1844-1851.
6. Kondoh N, Wakatsuki T, Ryo A, Hada A, Aihara T, Horiuchi S, et al. Identification and characterisation of genes associated with human hepatocellular carcinogenesis. Cancer Res 1999;59:4990-4996.
7. Ng IO, Liang ZD, Cao L, Lee TK. DLC-1 is deleted in primary hepatocellular carcinoma and exerts inhibitory effects on the proliferation of hepatoma cell lines with deleted DLC-1. Cancer Res 2000;60:6581-6584.
8. Zhao X, Li J, He Y, Lan F, Guo J, Zhao R, et al. A novel growth suppressor gene on chromosome 17p13.3 with a high frequency of mutation in human hepatocellular carcinoma. Cancer Res 2001;61:7383-7387.
9. Yamashita T, Kaneko S, Hashimoto S, Sato T, Nagai S, Toyoda N, et al. Serial analysis of gene expression in chronic hepatitis C and hepatocellular carcinoma. Biochem Biophys Res Commun 2001;282:647-654.
10. Ricketts SL, Garcia NF, Betz BL, Coleman WB. Identification of candidate liver tumour suppressor genes from human 11p11.2-p12. Genes Chromosomes Cancer 2002;33:47-59.
11. Yamamoto Y, Sakamoto M, Fujii G, Kanetaka K, Asaka M, Hirohashi S. Cloning and characterisation of a novel gene, DRH1, down-regulated in advanced human hepatocellular carcinoma. Clin Cancer Res 2001;7:297-303.
12. Kozak M. Downstream secondary structure facilitates recognition of initiator codons by eukaryotic ribosomes. Proc Natl Acad Sci 1990;87:8301-8305.
13. Connolly KC, Gabra H, Millwater CJ, Taylor KJ, Rabiasz GJ, Watson JE, et al. Identification of a region of frequent loss of heterozygosity at 11q24 in colorectal cancer. Cancer Res 1999;59:2806-2809.
14. Gentile M, Wiman A, Thorstenson S, Loman N, Borg A, Wingren S. Deletion mapping of chromosome segment 11q24-q25, exhibiting extensive allelic loss in early onset breast cancer. Int J Cancer 2001;92:208-213.
15. Goldberg EK, Glendening JM, Karanjawala Z, Sridhar A, Walker GJ, Hayward NK, et al. Localisation of multiple melanoma tumour-suppressor genes on chromosome 11 by use of homozygosity mapping-of-deletions analysis. Am J Hum Genet 2000;67:417-431.
16. Mathew S, Shurtleff SA, Raimondi SC. Novel cryptic, complex rearrangements involving ETV6-CBFA2 (TEL-AML1) genes identified by fluorescence in situ hybridisation in pediatric patients with acute lymphoblastic leukemia. Genes Chromosomes Cancer 2001;32:188-193.
17. Launonen V, Stenback F, Puistola U, Bloigu R, Huusko P, Kytola S, et al. Chromosome 11q22.3-q25 LOH in ovarian cancer: association with a more aggressive disease course and involved subregions. Gynecol Oncol 1998;71:299-304.
18. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997;275:1943-1947.